[1]张海燕,唐 岚,廖春淑,等.急性白血病化疗后中性粒细胞缺乏合并感染患者临床特征及血清免疫因子检测临床意义[J].陕西医学杂志,2024,(2):239-242,251.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.020]
　ZHANG Haiyan,TANG Lan,LIAO Chunshu,et al.Clinical characteristics and clinical significance of serum immune factors in acute leukemia patients with post-chemotherapy neutropenia complicated with infection[J].,2024,(2):239-242,251.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.020]
点击复制

急性白血病化疗后中性粒细胞缺乏合并感染患者临床特征及血清免疫因子检测临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年2期
页码:
239-242,251
栏目:
临床研究
出版日期:
2024-02-05

文章信息/Info

Title:
Clinical characteristics and clinical significance of serum immune factors in acute leukemia patients with post-chemotherapy neutropenia complicated with infection
作者:
张海燕1; 唐 岚1; 廖春淑1; 罗 源1;  林晓静2
(1.阆中市人民医院,四川 阆中 637400; 2.川北医学院附属医院,四川 南充 637000)
Author(s):
ZHANG Haiyan; TANG Lan; LIAO Chunshu; LUO Yuan; LIN Xiaojing
(Langzhong People's Hospital,Langzhong 637400,China)
关键词:
急性白血病;  化疗;  中性粒细胞缺乏;  感染;  临床特征;  免疫因子
Keywords:
Acute leukemia;  Chemotherapy;  Neutropenia;  Infection;  Clinical features;  Immune factors
分类号:
R 733.71
DOI:
DOI:10.3969/j.issn.1000-7377.2024.02.020
文献标志码:
A
摘要:
目的:分析急性白血病化疗后中性粒细胞缺乏合并感染患者临床特征及血清免疫因子检测的临床意义。方法:选取接受化疗治疗的132例急性白血病中性粒细胞缺乏患者,根据是否合并感染分为感染组和未感染组,另取同期体检健康者为对照组,比较三组受试者一般资料,分析感染患者的临床特征,检测三组受试者的血清免疫因子[免疫球蛋白A(IgA)、IgG、IgM]、炎症因子[C-反应蛋白(CRP)、降钙素原(PCT)、白介素-8(IL-8)]水平,采用ROC曲线分析IgA、IgG及IgM对急性白血病中性粒细胞缺乏合并感染的诊断价值。结果:74例中性粒细胞缺乏合并感染的急性白血病患者主要感染部位为呼吸道(71.62%),感染类型以细菌性感染为主(90.54%); 74例感染患者共培养出87株病原菌,以革兰阴性菌为主(60.92%); 感染组的IgA、IgG、IgM水平明显高于未感染组和对照组,且未感染组高于对照组(均P<0.05); 感染组的CRP、PCT、IL-8水平明显高于未感染组和对照组,且未感染组高于对照组(均P<0.05); IgA、IgG、IgM水平诊断急性白血病患者中性粒细胞缺乏合并感染的AUC和截断值分别为0.827、2.31 g/L,0.921、13.87 g/L,0.834、1.56 g/L。结论:急性白血病中性粒细胞缺乏合并感染患者主要感染部位为呼吸道,并以革兰阴性菌占大多数; 血清免疫因子IgA、IgG、IgM对急性白血病患者化疗后中性粒细胞缺乏合并感染有良好的诊断价值。
Abstract:
Objective:To analyze the clinical characteristics and the clinical significance of serum immune factors in acute leukemia patients with post-chemotherapy neutropenia complicated with infection.Methods:A total of 132 patients with acute leukemia and neutropenia who received chemotherapy were selected and divided into infection group and non-infection group according to the presence or absence of infection.In the same period,healthy people were selected as the control group.The general data of the three groups were compared,and the clinical characteristics of the infected patients were analyzed.Serum immune factors(IgA,IgG,IgM)and inflammation factors(CRP,PCT,IL-8)levels were detected.ROC curve was used to analyze the diagnostic value of IgA,IgG and IgM in neutrophilic leukemia complicated with infection.Results:The main infection site of 74 acute leukemia patients with neutropenia and infection was respiratory tract(71.62%),and the main type of infection was bacterial infection(90.54%).A total of 87 strains of pathogenic bacteria were cultured from 74 patients with infection,mainly Gram-negative bacteria(60.92%).The levels of IgA,IgG and IgM in the infection group were significantly higher than those in the non-infection group and the control group,and the non-infection group was higher than the control group(all P<0.05).The levels of CRP,PCT and IL-8 in the infection group were significantly higher than those in the non-infection group and the control group,and the non-infection group was higher than the control group(all P<0.05).The AUC and cut-off values of IgA,IgG and IgM in the diagnosis of neutropenia and infection in patients with acute leukemia were 0.827 and 2.31 g/L,0.921 and 13.87 g/L,0.834 and 1.56 g/L,respectively.Conclusion:The main infection site of acute leukemia patients with neutropenia and infection is respiratory tract,and Gram-negative bacteria account for the majority.Serum immune factors IgA,IgG and IgM have good diagnostic value for acute leukemia patients with neutropenia and infection after chemotherapy.

参考文献/References:

[1] 孙慧宇,李梅君.替加环素治疗成人急性白血病化疗后中性粒细胞缺乏伴发热疗效及对患者凝血功能、炎症因子的影响[J].陕西医学杂志,2021,50(11):1437-1440.
[2] 刘颖,陈艳,万叶明,等.CRP与PCT和IL-6早期诊断儿童急性白血病化疗期间骨髓抑制合并感染的临床价值[J].中华医院感染学杂志,2020,30(18):2855-2858.
[3] 李妍,孙成栋,赵弘.急性白血病患者化疗后下呼吸道大肠埃希菌感染的危险因素分析[J].临床和实验医学杂志,2019,18(9):1001-1003.
[4] 王海南,孙艳舫,杨淑莲.益气养阴方治疗骨髓抑制期气阴两虚型急性白血病临床研究[J].陕西中医,2022,43(4):465-468.
[5] REID J H,MARINI B L,BENITEZ L L,et al.Propensity-score matched comparison of salvage chemotherapy regimens in relapsed/refractory acute myeloid leukemia[J].Lymph Myelom Leuk,2021,21(6):393-400.
[6] 乔谷媛,陈必良,谭明华.妊娠合并白血病22例临床分析[J].陕西医学杂志,2019,48(9):1141-1146.
[7] 李海波,陈静娴,冼朝丽.血清vWF、IL-6、PCT及凝血功能指标在急性白血病合并感染患者诊断中的应用[J].海南医学,2021,32(5):580-583.
[8] 陈满强.重组人粒细胞刺激因子联合抗菌药物对急性白血病化疗后中性粒细胞缺乏合并感染患者血清炎症因子的影响研究[J].山西医药杂志,2019,48(16):1998-2000.
[9] 李平,黄纯.急性白血病患者合并血流感染的病原学、耐药现状及预后高危因素分析[J].中国病原生物学杂志,2021,16(9):1087-1090,1095.
[10] VERSCHUEREN E,HUSAIN B,YUEN K,et al.The immunoglobulin superfamily receptome defines cancer-relevant networks associated with clinical outcome[J].Cell,2020,182(2):329-344.
[11] 唐玉秀,蒋世海.Treg、NK细胞联合免疫球蛋白及肿瘤标志物评估化疗对进展期胃癌免疫功能影响[J].中国临床研究,2019,32(9):1210-1214.
[12] 郭靖,姜小建,李红妮.白血病中性粒细胞缺乏期伴感染患者中血清指标水平及其与细菌类型的关系[J].癌症进展,2021,19(21):2229-2232.
[13] 中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-321.
[14] 中华人民共和国卫生部医政司.全国临床检验操作规程[M].4版.北京:人民卫生出版社,2015:636-638.
[15] MARZGUIOUI S E,BENAMEUR S,BABAKHOUYA A,et al.Acute myelogenous leukemia revealed by acute appendicitis[J].Apollo Medicine,2020,17(1):40.
[16] LV X Y,LI Z J.Reduced plasma coagulation factor  in patients with acute leukemia in remission during consolidation chemotherapy cycles[J].Ann Hematol,2023,102(7):1739-1744.
[17] 王雪梅,汤久慧,王茂生.参芪杀白汤为主联合化疗治疗急性白血病合并脾周围炎临床研究[J].陕西中医,2020,41(2):202-205.
[18] 徐璐,苏群豪,王娇,等.IL-6和PCT与Activin-A对急性白血病患者化疗后感染的诊断价值[J].中华医院感染学杂志,2020,30(4):531-535.
[19] EGAWA G,ROEDIGER B,TAY S S,et al.Bacterial antigen is directly delivered to the draining lymph nodes and activates CD8+ T cells during Staphylococcus aureus skin infection[J].Immunol Cell Biol,2020,99(3):299-308.
[20] 李敏燕,王继红,王吉刚,等.血液病住院患者血流感染病原菌分布及耐药性分析[J].临床军医杂志,2021,49(11):1261-1263.
[21] ORTH-HOLLER D,EIGENTLER A,STIASNY K,et al.Kinetics of SARS-CoV-2 specific antibodies(IgM,IgA,IgG)in non-hospitalized patients four months following infection[J].J Infect,2021,82(2):282-327.
[22] PAN J,YU L,WU Q,et al.Integration of IgA and IgG autoantigens improves performance of biomarker panels for early diagnosis of lung cancer[J].Mol Cell Proteomics,2020,19(3):490-500.
[23] BOROCHOVA K,NIESPODZIANA K,FOCKE-TEJKL M,et al.Dissociation of the respiratory syncytial virus F protein-specific human IgG,IgA and IgM response[J].Sci Rep,2021,11(1):3551.
[24] 杨莹,关红梅,王舒,等.脑脊液与血清IGF-1、IGF-2、IGFBP-3、IL-2、IL-6、IL-8在急性淋巴细胞性白血病中的表达水平及意义[J].热带医学杂志,2020,20(11):1438-1441.
[25] 施青青,孙幸,吴蔚,等.血清免疫球蛋白检测在急性白血病患者中的临床意义[J].检验医学与临床,2020,17(20):2975-2977,2981.

相似文献/References:

[1]聂泽强,李晓云,马爻芳,等.WT1基因在骨髓增生异常综合征患者外同血中的表达及临床意义[J].陕西医学杂志,2019,(8):977.
　NIE Zeqiang,LI Xiaoyun,MA Yaofang,et al.Expression of WT1 gene in patients with Myelodysplastic syndrome[J].,2019,(2):977.
[2]彭 峰,彭奕华,张宏华,等.非小细胞肺癌化疗前后血清糖类抗原125、肿瘤异常蛋白水平变化及其与疗效的关系[J].陕西医学杂志,2020,49(7):851.[doi:DOI:10.3969/j.issn.10007377.2020.07.023]
　PENG Feng,PENG Yihua,ZHANG Honghua,et al.Changes of serum CA125 and TAP levels before and after chemotherapy for non-small cell lung cancer and their relationship with curative effect[J].,2020,49(2):851.[doi:DOI:10.3969/j.issn.10007377.2020.07.023]
[3]杨 昕,刘 芳,杜 静,等.肺癌癌组织中过氧化物酶增殖体激活受体γ基因表达水平对培美曲塞化疗疗效的预测价值*[J].陕西医学杂志,2020,49(10):1359.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.042]
　YANG Xin,LIU Fang,DU Jing,et al.Predictive value of PPARγ gene expression level in lung cancer tissue for curative effect of pemetrexed chemotherapy[J].,2020,49(2):1359.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.042]
[4]邵渊.上颌窦癌临床特征及治疗[J].陕西医学杂志,2021,50(4):387.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.001]
[5]雷 普,卢红梅,卜小斌,等.新型内分泌联合化疗治疗高危前列腺癌临床研究[J].陕西医学杂志,2021,50(4):454.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.018]
[6]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
　CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(2):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[7]孙慧宇,李梅君.替加环素治疗成人急性白血病化疗后中性粒细胞缺乏伴发热疗效及对患者凝血功能、炎症因子的影响[J].陕西医学杂志,2021,50(11):1437.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.029]
　SUN Huiyu,LI Meijun.Curative effect of tigecycline in treatment of neutrophil deficiency with fever after chemotherapy in adult acute leukemia and its effect on coagulation function and inflammatory factors in patients[J].,2021,50(2):1437.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.029]
[8]郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
　ZHENG Chao,SU Juan,SHENG Jiexin,et al.Correlation between focal blood flow time-signal intensity curve type,apparent diffusion coefficient and chemotherapy efficacy in breast cancer patients[J].,2021,50(2):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
[9]孟璠璐,刘 瑜,程 轩,等.小细胞肺癌药物治疗研究进展[J].陕西医学杂志,2022,51(10):1313.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.034]
　MENG Fanlu,LIU Yu,CHENG Xuan,et al.New advances in drug therapy for small cell lung cancer[J].,2022,51(2):1313.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.034]
[10]赵 鹏,刘 冬,兰 飞,等.非小细胞肺癌化疗前后血清糖类抗原125、基质金属蛋白酶-9、可溶性程序性死亡配体1水平变化及其与疗效关系研究[J].陕西医学杂志,2022,51(12):1564.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.023]
　ZHAO Peng,LIU Dong,LAN Fei,et al.Changes of serum CA125,MMP-9 and sPD-L1 levels before and after chemotherapy in non-small cell lung cancer and their relationship with therapeutic effect[J].,2022,51(2):1564.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.023]

备注/Memo

备注/Memo:
基金项目:四川省南充市社会科学研究项目(NC22B258)
更新日期/Last Update: 2024-02-05